Chemicals

Saposin C22

<p>Saposin C22 is a synthetic peptide derived from the saposin C domain, designed to mimic the function of the endogenous saposin C protein. It serves as a potent activator of glucocerebrosidase (GCase), enhancing the enzyme&#39;s ability to hydrolyze glucosylceramide in lysosomes. This product is primarily utilized in research settings to study lysosomal function, lipid metabolism, and as a tool for investigating t…

SupplierGlobal Technology Co., Ltd.www.hqtechtirz.com
Source categories

About this product

Product information from the supplier.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
Saposin C22
CAS NO.
/
Appearance
White to off-white lyophilized powder
Molecular Formula
C116H196N28O37S
Molecular Weight
2607.08g/mol 
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water, PBS, or dilute acetic acid. It is recommended to dissolve in sterile water or buffer to prepare stock solutions for biological assays.

Endotoxin< 1.0 EU/mg (Typical for research-grade peptides)
Biological Activity
Saposin C22 is a potent vasoconstrictor and bronchoconstrictor. It acts as a selective agonist for the endothelin B (ETB) receptor, making it a valuable tool for studying endothelin receptor pharmacology and vascular physiology.
Storage Conditions
Store at -20°C or lower. For long-term storage, keep desiccated at -20°C. Upon reconstitution, aliquot and store at -20°C to avoid repeated freeze-thaw cycles.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Saposin C22 functions by binding to glucocerebrosidase (GCase) and facilitating its interaction with lipid substrates within the lysosomal membrane. It acts as a co-factor that enhances the enzymatic activity of GCase, promoting the hydrolysis of glucosylceramide into glucose and ceramide. This mechanism is crucial for maintaining lipid homeostasis and preventing the accumulation of toxic lipid species in cells.


2.PRODUCT INDICATIONS

This product is indicated for use in preclinical research to investigate the role of saposin C in lysosomal biology and lipid metabolism. It is employed in studies focusing on Gaucher disease, Parkinson's disease (where GCase dysfunction is implicated), and other lysosomal storage disorders. Additionally, it is used to screen for potential therapeutic agents that modulate GCase activity.


3.CLINICAL EFFICACY OF PRODUCT

While Saposin C22 is not approved for clinical use, research demonstrates its efficacy in restoring GCase activity in cellular models of Gaucher disease. Studies show that supplementation with saposin C can rescue enzyme function in cells with deficient GCase activity, reducing lipid accumulation and improving lysosomal function. These findings support its potential as a therapeutic candidate for disorders involving GCase impairment.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.